Real World Effectiveness of Sotrovimab in Preventing COVID-19–Related Hospitalisation or Death in Patients Infected with Omicron BA.2
Journal of Infection and Public Health This article finds that Sotrovimab was effective in reducing COVID-19 progression risk in high-risk BA.2 variant-infected patients. Journal Article
Read More